首页|Metallofullerenols in biomedical applications

Metallofullerenols in biomedical applications

扫码查看
原文链接
  • NSTL
Metallofullerenols (MFs) are functionalized endohedral fullerenes connecting at least three levels of organization of matter: atomic, molecular, and supramolecular, resulting in their unique activity at the nanoscale. Biomedical applications of MFs started from gadolinium-containing contrasting agents, but today their potential medical applications go far beyond diagnostics and magnetic resonance imaging. In many cases, preclinical studies have shown a great therapeutic value of MFs, and here we provide an overview of interactions of MFs with highenergy radiation and with reactive oxygen species generated during radiation as a ground for potential applications in modern therapy of cancer patients. We also present the current knowledge on interactions of MFs with proteins and with other components of cells and tissues. Due to their antioxidant properties, as well as their ability to regulate the expression of genes involved in apoptosis, angiogenesis, and stimulation of the immune response, MFs can contribute to inhibition of tumor growth and protection of normal cells. MFs with enclosed gadolinium act as inhibitors of tumor growth in targeted therapy along with imaging techniques, but we hope that the data gathered in this review will help to accelerate further progress in the implementation of MFs, also the ones containing rare earth metals other than gadolinium, in a broad range of bioapplications covering not only diagnostics and bioimaging but also radiation therapy and cancer treatment by not-cytotoxic agents.

MetallofullereneMetallofullerenolRadiation therapyMRI contrast AgentTherapeuticsReactive oxygen speciesHYDROXYLATED FULLERENE C-60ENDOHEDRAL METALLOFULLERENESRADIATION-RESISTANCEIN-VIVOMOLECULAR-MECHANISMHIGH-EFFICIENCYM-AT-C-82 MHIGH-YIELDNANOPARTICLESGD-AT-C-82(OH)(22)

Grebowski, Jacek、Litwinienko, Grzegorz

展开 >

Fac Biol & Environm Protect,Univ Lodz

Fac Chem,Univ Warsaw

2022

10.1016/j.ejmech.2022.114481

European Journal of Medicinal Chemistry

European Journal of Medicinal Chemistry

CCR
ISSN：0223-5234
年,卷(期)：2022.238
  • 4
  • 153